Vaccine Targets Articles & Analysis
15 articles found
Whether it is medical research or drug manufacturing, tablet press is a vital link. Let's see how to choose the one that suits you best.Grand pack.The field of drug delivery is constantly evolving, driven by the core goal of improving therapeutic outcomes—enhancing efficacy, reducing toxicity, boosting patient compliance, and even enabling entirely new medical treatments. The global drug delivery ...
Advantages of Recombinant Vaccines Recombinant vaccines come with several notable benefits: Safety: Since these vaccines do not contain live pathogens, there is a significantly reduced risk of causing disease in vaccinated individuals. ...
In recent years, messenger RNA (mRNA) technology has emerged as a revolutionary approach in the field of medicine, particularly in vaccine development and gene therapy. The ability to deliver mRNA effectively to target cells is crucial for harnessing its potential in treating a variety of diseases, including infectious diseases, cancer, and genetic disorders. ...
Furthermore, custom mRNA production holds immense potential in vaccine development, offering a rapid and adaptable approach to creating vaccines against infectious diseases. By designing custom mRNA vaccines to target specific proteins on viruses or bacteria, researchers can stimulate a swift and effective immune response. ...
This article explores the intricate and indispensable role that raw enzymes play in the manufacturing of mRNA vaccines, delving deep into their significance and impact on vaccine production. ...
The SARS-CoV-2 outbreak and subsequent race in vaccine development can provide strategies to the scientific community to avoid a flavivirus pandemic. ...
Longlong Si's research group from the Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, published a research titled "Generation of a live attenuated influenza A vaccine by proteolysis targeting" in Nature Biotechnology. Using influenza virus as a model virus, the team established the technology of protein ...
Therefore, HLA typing is beneficial for research on immune-related diseases, screening of vaccine and drug targets, research of evolution, and transplantation. ...
Predicting and developing novel drug targets and biomarkers by cancer bioinformatics improves the speed and targeting ability of new therapies and drug development. ...
After being exposed to malaria, control monkeys that had not been vaccinated developed parasite levels three and a half times that of the vaccinated monkeys. ...
Last week, the product manager of Creative Enzymes announced the launch of neuraminidase, which is expected to further develop a new universal influenza vaccine. Neuraminidase is a drug target to prevent the spread of influenza infection. ...
Abstract Background Although herpes simplex viruses (HSV) are a major target for vaccine development no vaccine is currently licensed. Methods A live attenuated HSV virus vaccine, VC2 was compared to a subunit HSV vaccine, glycoprotein D (gD2) administered with the adjuvant, MPL/Alum using the guinea pig model ...
Here, we tested a prophylactic live-attenuated vaccine against herpes simplex virus type 1 (HSV-1), a widespread human pathogen that can cause corneal blindness. ...
Proteomics research is focused on developing drugs, detecting potential therapeutic targets, diagnostics, vaccine development, searching for biomarkers and other related fields. ...
Malaria is a vector-borne infectious disease caused by protozoan parasite of the genus Plasmodium. The malaria vaccine which has been studied is designed to induce immunity to the sporozoite and to kill sporozoite-infected liver cells. ...